Beyond the Usual: Novel Therapeutic Roles for Established Antidotes

Area of Science:

• Medical Toxicology
• Pharmacology
• Drug Discovery

Background:

• Antidotes are critical for treating toxic substance exposure.
• Fomepizole, l-carnitine, and naloxone are established antidotes with potential new applications.
• Understanding evolving antidote therapies is crucial for patient outcomes.

Purpose of the Study:

• Review emerging evidence for novel indications of fomepizole, l-carnitine, and naloxone.
• Inform clinicians and researchers on updated antidote practices.
• Identify areas for future research in antidote therapy.

Main Methods:

• Narrative literature review.
• Analysis of existing evidence on antidote efficacy.
• Identification of new treatment avenues for specific intoxications.

Main Results:

• Fomepizole shows potential for paracetamol poisoning due to CYP2E1 and JNK pathway inhibition.
• L-carnitine offers benefits beyond valproic acid toxicity, including general drug intoxication treatment.
• Naloxone demonstrates efficacy for clonidine and ACE inhibitor overdoses, expanding its use beyond opioids.

Conclusions:

• Repurposing fomepizole, l-carnitine, and naloxone is a key development in precision toxicology.
• Matching antidotes to molecular toxicity signatures enhances treatment efficacy.
• Further research is warranted to optimize the use of these repurposed antidotes.